Pharma BD Deal Intelligence

The Deal Library

Browse 1,610 pharma and biotech BD deals, $5414.1B in disclosed deal value, 899 with a post-close Outcome Score, organized by year, acquirer, and therapeutic area. Each deal is graded on announcement reception and post-close outcome.

Interactive search & filters  ·  How we score deals

By year

• 2026 (259)
• 2025 (190)
• 2024 (126)
• 2023 (61)
• 2022 (56)
• 2021 (66)
• 2020 (62)
• 2019 (69)
• 2018 (43)
• 2017 (47)
• 2016 (57)
• 2015 (56)
• 2014 (54)
• 2013 (46)
• 2012 (38)
• 2011 (36)
• 2010 (44)
• 2009 (35)
• 2008 (25)
• 2007 (30)
• 2006 (37)
• 2005 (36)
• 2004 (17)
• 2003 (23)
• 2002 (23)
• 2001 (33)
• 2000 (21)
• 1999 (4)
• 1998 (3)
• 1997 (1)
• 1996 (1)
• 1995 (4)
• 1994 (3)
• 1991 (1)
• 1989 (1)
• 1974 (1)
• 1895 (1)

By acquirer

• Abbott Laboratories (15)
• AbbVie Inc. (41)
• Actavis plc (3)
• Alexion Pharmaceuticals Inc. (5)
• Allergan plc (14)
• Amgen Inc. (19)
• Astellas Pharma Inc. (12)
• AstraZeneca PLC (60)
• Bayer AG (24)
• Biogen Inc. (14)
• BioMarin Pharmaceutical Inc. (3)
• BioNTech SE (4)
• Boehringer Ingelheim GmbH (6)
• Boehringer Ingelheim International GmbH (11)
• Boston Scientific Corporation (4)
• Bristol-Myers Squibb Company (53)
• Celgene Corporation (13)
• Cephalon Inc. (13)
• Chugai Pharmaceutical Co. Ltd. (3)
• Cubist Pharmaceuticals, Inc. (4)
• Daiichi Sankyo Company, Limited (5)
• Danaher Corporation (3)
• Eisai Co., Ltd. (3)
• Eli Lilly and Company (77)
• Endo Health Solutions Inc. (4)
• Endo International plc (4)
• Endo Pharmaceuticals Inc. (7)
• Everest Medicines Limited (3)
• F. Hoffmann-La Roche AG (6)
• Forest Laboratories, Inc. (3)
• Genentech, Inc. (Roche Group) (9)
• Genmab A/S (3)
• Genzyme Corporation (6)
• Gilead Sciences Inc. (26)
• GlaxoSmithKline plc (25)
• GSK plc (28)
• H. Lundbeck A/S (3)
• Hologic, Inc. (3)
• Horizon Pharma plc (3)
• Hospira Inc. (5)
• Illumina, Inc. (3)
• Incyte Corporation (7)
• Inverness Medical Innovations Inc. (5)
• Ipsen S.A. (9)
• Jazz Pharmaceuticals PLC (5)
• Johnson & Johnson (32)
• King Pharmaceuticals Inc. (3)
• LEO Pharma A/S (3)
• Lonza Group AG (3)
• Madrigal Pharmaceuticals (3)
• Mallinckrodt plc (6)
• Merck & Co. Inc. (50)
• Merck & Co., Inc. (3)
• Merck KGaA (11)
• Mylan Inc. (5)
• Mylan Laboratories Inc. (4)
• Mylan N.V. (5)
• Neurocrine Biosciences Inc. (3)
• Novartis AG (58)
• Novo Nordisk A/S (18)
• Nycomed (3)
• Otsuka Pharmaceutical Co., Ltd. (5)
• Pathos AI, Inc. (3)
• Pfizer Inc. (63)
• Reckitt Benckiser plc (4)
• Recordati S.p.A. (3)
• Regeneron Pharmaceuticals, Inc. (8)
• Roche Holding AG (68)
• Royalty Pharma (4)
• Sanofi SA (55)
• Sanofi-Aventis (7)
• Schering-Plough Corp. (4)
• Servier (9)
• Servier Pharmaceuticals LLC (3)
• Shire plc (11)
• Stryker Corporation (5)
• Sumitomo Dainippon Pharma Co., Ltd. (4)
• Sun Pharmaceutical Industries Ltd. (6)
• Swedish Orphan Biovitrum AB (6)
• Takeda Pharmaceutical Company Ltd. (25)
• Teva Pharmaceutical Industries Ltd. (19)
• Thermo Fisher Scientific Inc. (7)
• UCB S.A. (5)
• Valeant Pharmaceuticals International, Inc. (9)
• Vertex Pharmaceuticals Incorporated (12)
• Watson Pharmaceuticals (Actavis Inc.) (9)
• Zimmer Holdings Inc. (3)

By therapeutic area

• Cardiovascular (83)
• Dermatology (51)
• Gastroenterology (42)
• Gene Therapy (24)
• Hematology (87)
• Immunology (95)
• Infectious Disease (70)
• Metabolic (49)
• Multiple (5)
• Multiple (undisclosed) (33)
• Nephrology (17)
• Neurology (111)
• Oncology (268)
• Ophthalmology (17)
• Other (82)
• Rare Disease (29)
• Respiratory (25)
• Vaccines (12)
• Women's Health (8)